ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,113 | +7.8% | 84,681 | +4.6% | 0.02% | +11.1% |
| Q2 2023 | $1,609,114 | +8.7% | 80,982 | -6.3% | 0.02% | +5.9% |
| Q1 2023 | $1,479,929 | -41.3% | 86,394 | -33.0% | 0.02% | -41.4% |
| Q4 2022 | $2,522,850 | +80.5% | 128,914 | +47.7% | 0.03% | +70.6% |
| Q3 2022 | $1,398,000 | +15.7% | 87,253 | -0.5% | 0.02% | +21.4% |
| Q2 2022 | $1,208,000 | -7.5% | 87,661 | +6.6% | 0.01% | 0.0% |
| Q1 2022 | $1,306,000 | -5.4% | 82,236 | +29.4% | 0.01% | 0.0% |
| Q4 2021 | $1,381,000 | -5.5% | 63,573 | +29.8% | 0.01% | -6.7% |
| Q3 2021 | $1,461,000 | -21.7% | 48,962 | +16.2% | 0.02% | -16.7% |
| Q2 2021 | $1,867,000 | +33.5% | 42,138 | +33.8% | 0.02% | +12.5% |
| Q1 2021 | $1,398,000 | -47.0% | 31,500 | -34.5% | 0.02% | -46.7% |
| Q4 2020 | $2,639,000 | +104.7% | 48,072 | -14.7% | 0.03% | +76.5% |
| Q3 2020 | $1,289,000 | +19.5% | 56,385 | +9.4% | 0.02% | +6.2% |
| Q2 2020 | $1,079,000 | +0.3% | 51,544 | -33.2% | 0.02% | +6.7% |
| Q1 2020 | $1,076,000 | +45.4% | 77,178 | +137.5% | 0.02% | +50.0% |
| Q4 2019 | $740,000 | – | 32,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |